When was Zyl Therapeutics founded?

Zyl Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Where is Zyl Therapeutics located?

Zyl Therapeutics is headquartered in Greenville, United States.

How many employees does Zyl Therapeutics have?

As of Aug 31, 2026, the latest employee count at Zyl Therapeutics is 3.

Is Zyl Therapeutics a funded company?

Zyl Therapeutics is a funded company, having raised a total of $9.42M across 9 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2018.

When was the latest funding round of Zyl Therapeutics?

Zyl Therapeutics' latest funding was a $***** Grant (prize money) round on Sep 12, 2025, with participation from 1 investor. Its primary sector is Drug Delivery. In United States, the Drug Delivery sector has seen $245M in funding in 2026 to date.

Where does Zyl Therapeutics rank among its competitors?

Zyl Therapeutics ranks 32nd amongst 213 active competitors, of which 62 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was ViaNautis, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of Zyl Therapeutics?

Zyl Therapeutics' top competitors include Sirnaomics, PolyPid and Avadel Pharmaceuticals. Among them, ViaNautis secured the most recent funding round in September, 2026.

Zyl Therapeutics - 2026 Company Profile, Funding & Competitors

Zyl Therapeutics is a series B company based in Greenville (United States), founded in 2017. It operates as a Developer of hydrogel-derived nanoparticle system for topical applications. Zyl Therapeutics has raised $9.42M in funding from investors like VentureSouth, New York Angels and Boston Harbor Angels. The company has 213 active competitors, including 62 funded and 17 that have exited. Its top competitors include companies like Sirnaomics, PolyPid and Avadel Pharmaceuticals.

Company Details

Developer of hydrogel-derived nanoparticle system for topical applications. The company has developed a patented drug delivery system Nanopods, a hydrogel-derived nanoparticle system. The system can be used to deliver payloads such as nitric oxide, curcumin, cannabis, siRNA, iron, and melanin topically.

Website: www.zylotherapeutics.com/
Social
Email ID: *****@zylotherapeutics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2017

Location

Greenville, United States

Stage

Series B

Total Funding

$9.42M in 9 rounds

Latest Funding Round

Grant (prize money), Sep 12, 2025, $*****

Investors

VentureSouth & 14 more

Ranked

32^nd among 213 active competitors

Employee Count

3 as on Aug 31, 2026

Similar Companies

Sirnaomics & 244 more

View Zyl Therapeutics' full profile

Zyl Therapeutics has raised a total funding of $9.42M over 9 rounds. Its first funding round was on 2018. Its latest funding round was a Grant (prize money) round on Sep 12, 2025 for $*****. 1 investor participated in its latest round. Zyl Therapeutics has 15 institutional investors.

Here is the list of recent funding rounds of Zyl Therapeutics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 12, 2025	5858676	Grant (prize money)	3808713	2967220	3909266	9125850
Aug 06, 2025	3867694	Grant (prize money)	9838409	7252859	7875939	HHS
Jan 27, 2025	5366754	Grant (prize money)	5145555	5228407	5272571	HHS

Access funding benchmarks and valuations. Sign up today!

View details of Zyl Therapeutics's funding rounds and investors

Zyl Therapeutics' employee count trend

Zyl Therapeutics has 3 employees as of Aug 26. Here is Zyl Therapeutics's employee count trend over the years:

Employee count trend for Zyl Therapeutics

Uncover Zyl Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Zyl Therapeutics include Sirnaomics, PolyPid and Avadel Pharmaceuticals. Here is the list of Top 10 competitors of Zyl Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sirnaomics 2007, Gaithersburg (United States), Public	Developer of RNA based therapeutics for the treatment of cancer and fibrosis disease	$267M	Rotating Boulder Fund, Walvax & 16 others	67/100
2nd	PolyPid 2008, Petah Tikva (Israel), Public	Technology platform enabling controlled and prolonged release of any Active Pharmaceutical Ingredient (API)	$96.7M	Shavit Capital, Aurum Ventures & 6 others	66/100
3rd	Avadel Pharmaceuticals 1990, Dublin (Ireland), Acquired	Pharma company with proprietary drug delivery tools and drug for narcolepsy	-	Venrock, RTW Investments & 4 others	61/100
4th	Splice Bio 2020, Barcelona (Spain), Series B	Provider of a proprietary platform for gene therapy	$192M	Ysios Capital, EQT & 9 others	57/100
5th	Arcturus Therapeutics 2013, San Diego (United States), Public	Developer of RNAi technologies for the treatment of rare orphan diseases	$1.3M	Cystic Fibrosis Foundation, JLABS & 1 others	56/100
6th	NanoViricides 2005, West Haven (United States), Public	Targeted antiviral therapeutics	-	-	54/100
7th	PanTher Therapeutics 2014, Cambridge (United States), Series B	Provider of drug delivery system for cancer treatment	$15.4M	CHV, Mission BioCapital & 9 others	54/100
8th	ViaNautis 2018, Cambridge (United Kingdom), Series A	Developer of targeted nanomedicines for drug delivery	$25M	4Bio Capital, Origin Capital & 8 others	55/100
9th	RS Research 2015, Pendik (Turkey), Series A	Developer of smart nanomedicines and targeted oncology therapies using polymer-drug conjugate platforms	$14.3M	ACT, Gen & 4 others	53/100
10th	Lexaria Bioscience 2004, Kelowna (Canada), Public	Developer of drug delivery technology designed to improve drug absorption	$45K	-	53/100
32nd	Zyl Therapeutics 2017, Greenville (United States), Series B	Developer of hydrogel-derived nanoparticle system for topical applications	$9.42M	Mohan Growth Partners, KTECH Capital & 13 others	40/100